Frikke-Schmidt, Henriette http://orcid.org/0000-0002-1529-0755
Arvan, Peter http://orcid.org/0000-0002-4007-8799
Seeley, Randy J. http://orcid.org/0000-0002-3721-5625
Cras-Méneur, Corentin http://orcid.org/0000-0001-8921-8927
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK048280, DK117821)
Article History
Received: 27 August 2020
Accepted: 8 December 2020
First Online: 12 January 2021
Competing interests
: Randy Seeley serves as a consultant for Novo Nordisk, Scohia, Kintai Therapeutics and Ionis. He also received research support from Novo Nordisk, Zafgen, Astra Zeneca, Pfizer and Ionis and equity from Zafgen and Redesign Health. None of the other authors share any competing interest.